On April 11, 2025, Longevity Health Holdings, Inc. signed a merger agreement to merge with 20/20 Biolabs, Inc., with the deal subject to various conditions, including raising at least $4 million in financing. Additionally, on April 14, 2025, the company announced an at-the-market offering to sell up to $2 million in shares.